Overexpression of AZGP1 mRNA (n = 125, based on top quartile expression) correlated to longer overall survival in HNSCC patients, although low AZGP1 mRNA levels (n = 124, based on bottom quartile expression) did not portend a worse overall outcome. The gene discussed is AZGP1; the disease is head and neck squamous cell carcinoma.